Neuronal molecular mimicry as a cause of immune-mediated neurologic disease of the central nervous system (CNS)

被引:0
|
作者
Levin, MC
Lee, SM
Morcos, Y
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A527 / A527
页数:1
相关论文
共 50 条
  • [31] CONTROL OF IMMUNE-MEDIATED DISEASE OF THE CENTRAL-NERVOUS-SYSTEM REQUIRES THE USE OF A NEUROACTIVE AGENT - ELUCIDATION BY THE ACTION OF MITOXANTRONE
    BAKER, D
    ONEILL, JK
    DAVISON, AN
    TURK, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 90 (01): : 124 - 128
  • [32] Editorial: Epidemiology, diagnosis, prognosis and treatment of rare immune-mediated diseases of the central nervous system
    Willekens, Barbara M. P.
    Kleffner, Ilka
    Wokke, Beatrijs
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [33] Central Nervous System Lymphatics and Impact on Neurologic Disease
    Nistal, Dominic
    Mocco, J.
    WORLD NEUROSURGERY, 2018, 109 : 449 - 450
  • [34] Molecular diagnosis of the central nervous system (CNS) infections
    Vila, Jordi
    Bosch, Jordi
    Munoz-Almagro, Carmen
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2021, 39 (08): : 403 - 410
  • [35] Neuronal regulation of immune responses in the central nervous system
    Tian, Li
    Rauvala, Heikki
    Gahmberg, Carl G.
    TRENDS IN IMMUNOLOGY, 2009, 30 (02) : 91 - 99
  • [36] Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes
    Kukreja, A
    Maclaren, NK
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (04) : 534 - 541
  • [37] Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes
    A. Kukreja
    N. K. Maclaren*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 534 - 541
  • [38] Immune mediated demyelination in the central nervous system
    Linington, C
    BRAIN PATHOLOGY, 1997, 7 (04) : 1235 - 1235
  • [39] The role of macrophages in immune-mediated damage to the peripheral nervous system
    Kiefer, R
    Kieseier, BC
    Stoll, G
    Hartung, HP
    PROGRESS IN NEUROBIOLOGY, 2001, 64 (02) : 109 - 127
  • [40] Potential scope of action of tissue kallikreins in CNS immune-mediated disease
    Scarisbrick, I. A.
    Blaber, S. I.
    Tingling, J. T.
    Rodriguez, M.
    Blaber, M.
    Christophi, G. P.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 (1-2) : 167 - 176